| |
| |
|
| Insider
Information: |
Oliviero James F Iii |
| Relationship: |
Director |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
2,221,014 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$3,783,364 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
2,221,014 |
|
|
| Total
Value |
$3,783,364 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
15
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
15
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-15.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -763.7%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Keryx Biopharmaceuticals Inc |
KERX |
Chief Financial Officer |
2015-07-06 |
209,406 |
2008-08-14 |
0 |
Premium* |
|
|
Checkpoint Therapeutics, Inc. |
CKPT |
CEO, President and Dir... |
2024-05-24 |
2,001,780 |
|
0 |
Premium* |
|
|
Nuvectis Pharma, Inc. |
NVCT |
Director |
2022-02-08 |
9,828 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
81 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| KERX |
Keryx Biopharmaceuticals ... |
Chief Financial Officer |
• – – |
2013-05-13 |
4 |
S |
$8.34 |
$244,887 |
D/D |
(29,363) |
558,842 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Financial Officer |
• – – |
2013-12-27 |
4 |
S |
$12.68 |
$380,400 |
D/D |
(30,000) |
525,929 |
0 |
- |
|
| CKPT |
Checkpoint Therapeutics, ... |
CEO, President and Director |
• • – |
2022-01-30 |
4 |
D |
$2.46 |
$78,651 |
D/D |
(31,972) |
3,077,301 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Financial Officer |
• – – |
2013-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
33,520 |
600,548 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Financial Officer |
• – – |
2010-06-08 |
4 |
S |
$3.97 |
$164,536 |
D/D |
(41,497) |
369,254 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Financial Officer |
• – – |
2015-05-12 |
4 |
OE |
$2.53 |
$111,095 |
D/D |
41,611 |
211,349 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Financial Officer |
• – – |
2011-06-06 |
4 |
S |
$4.99 |
$235,683 |
D/D |
(47,231) |
171,924 |
0 |
- |
|
| CKPT |
Checkpoint Therapeutics, ... |
CEO, President and Director |
• • – |
2021-02-05 |
4 |
S |
$3.42 |
$166,745 |
D/D |
(48,790) |
3,153,210 |
0 |
% |
|
| KERX |
Keryx Biopharmaceuticals ... |
Vice President, Finance |
• – – |
2009-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
330,000 |
0 |
- |
|
| CKPT |
Checkpoint Therapeutics, ... |
CEO, President and Director |
• • – |
2022-01-06 |
4 |
D |
$2.77 |
$146,876 |
D/D |
(53,024) |
3,252,409 |
0 |
- |
|
| CKPT |
Checkpoint Therapeutics, ... |
CEO, President and Director |
• • – |
2021-02-04 |
4 |
S |
$3.51 |
$245,525 |
D/D |
(70,000) |
3,202,000 |
0 |
% |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Financial Officer |
• – – |
2013-12-30 |
4 |
S |
$12.62 |
$1,003,890 |
D/D |
(79,500) |
476,429 |
0 |
- |
|
| CKPT |
Checkpoint Therapeutics, ... |
CEO, President and Director |
• • – |
2022-04-04 |
4 |
S |
$1.79 |
$154,572 |
D/D |
(86,353) |
2,873,291 |
0 |
% |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Financial Officer |
• – – |
2010-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
462,964 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Financial Officer |
• – – |
2010-12-02 |
4 |
S |
$5.01 |
$539,191 |
D/D |
(107,623) |
249,209 |
0 |
- |
|
| CKPT |
Checkpoint Therapeutics, ... |
CEO, President and Director |
• • – |
2022-02-24 |
4 |
D |
$1.85 |
$217,665 |
D/D |
(117,657) |
2,959,644 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Financial Officer |
• – – |
2014-03-20 |
4 |
S |
$15.04 |
$1,880,000 |
D/D |
(125,000) |
317,861 |
0 |
- |
|
| CKPT |
Checkpoint Therapeutics, ... |
CEO, President and Director |
• • – |
2022-01-24 |
4 |
D |
$2.19 |
$313,468 |
D/D |
(143,136) |
3,109,273 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Financial Officer |
• – – |
2014-09-08 |
4 |
S |
$15.88 |
$2,290,484 |
D/D |
(144,237) |
156,039 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Financial Officer |
• – – |
2014-03-19 |
4 |
S |
$15.23 |
$2,346,014 |
D/D |
(154,039) |
442,861 |
0 |
- |
|
| CKPT |
Checkpoint Therapeutics, ... |
CEO, President and Director |
• • – |
2022-06-17 |
4 |
S |
$1.09 |
$248,520 |
D/D |
(228,000) |
2,610,003 |
0 |
% |
|
| KERX |
Keryx Biopharmaceuticals ... |
Vice President Finance |
• – – |
2008-08-14 |
4 |
A |
$0.00 |
$0 |
D/D |
280,000 |
280,000 |
0 |
- |
|
| CKPT |
Checkpoint Therapeutics, ... |
CEO, President and Director |
• • – |
2022-01-01 |
4 |
D |
$3.11 |
$941,636 |
D/D |
(302,777) |
3,305,433 |
0 |
- |
|
| CKPT |
Checkpoint Therapeutics, ... |
CEO and President |
• – – |
2016-12-15 |
4 |
A |
$0.00 |
$0 |
D/D |
325,000 |
1,325,000 |
0 |
- |
|
| CKPT |
Checkpoint Therapeutics, ... |
CEO and President |
• – – |
2018-01-30 |
4 |
A |
$0.00 |
$0 |
D/D |
325,000 |
1,650,000 |
0 |
- |
|
81 Records found
|
|
Page 3 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
